2025 MSK Pulmo-Oncology Symposium

Pulmo-oncology is an emerging discipline at the intersection of pulmonary medicine and oncology, playing a critical role in the clinical care of patients with cancer. The respiratory system is often impacted by direct cancer involvement and toxicities stemming from the use of anti-neoplastic agents. Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.

Now in its third year, this symposium brings together global experts from multiple disciplines to present the latest advances in cancer therapies and best practices in the evaluation and management of lung disease. Through state-of-the-art presentations and interdisciplinary, case-based discussions, this symposium will explore key topics related to the care of cancer patients with pulmonary comorbidities and complications arising from cancer or its treatments.

Key topics for this year's program include:

• State-of-the-art updates in lung cancer treatment

• Navigating immune-mediated lung toxicities related to cancer therapy

• Clinical strategies for prevention, symptom management, and co-existing conditions

Complex cases will be presented throughout, with dedicated time for interactive, multidisciplinary panel discussions to encourage meaningful engagement between participants and the faculty.

Format & Audience: This symposium offers the option to attend either in person or virtually and is intended for healthcare professionals in pulmonology, hematology/oncology, and related disciplines involved in the care of cancer patients or those with a special interest in this area.

Post-Symposium Resources: Registrants will receive access to a syllabus containing PDF versions of faculty presentation slides and recorded session videos after the symposium concludes.

1. Describe the role of the pulmonologist in diagnosis and management of cancer related pulmonary complications
2. Identify state of the art diagnostic and treatment strategies for management of lung cancer
3. Implement strategies for diagnosis and management of non-infectious pulmonary complications of stem cell transplant and other cancer directed therapies
4. Discuss multidisciplinary approach in complex patients
5. Gain new insights in the cancer risks and pulmonary complications of inhaled substances
6. Implement approaches to symptom management and management of long term pulmonary complications of cancer treatment

This symposium offers the option to attend either in person or virtually. Attendance type should be selected during registration.

Early Rates (available through August 8)

• Physicians (MDs, PhDs, DOs): $250

• Advanced Practice Providers: $200

• Nursing and Other Healthcare Professionals: $100

• Residents, Fellows, and Students: $50*

• Industry Professionals: not available (general rates apply)

General Rates (after August 8)

• Physicians (MDs, PhDs, DOs): $300

• Advanced Practice Providers: $250

• Nursing and Other Healthcare Professionals: $150

• Residents, Fellows, and Students: $100*

• Industry Professionals: $525**

*Registration fees for residents, fellows, and students are non-refundable.
**An “industry professional” is defined as any individual—regardless of profession (e.g., MD, PhD, APP, RN)—who is employed by an ineligible company. View our Registration Policy for Industry Professionals for more information.

Registration Discounts: Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information.

Meals and Accommodations: Continental breakfast, lunch, and refreshment breaks will be provided to in-person participants. If you have dietary restrictions or require special accommodations to attend in person, please contact us at [email protected] at least one week prior to the course.

Cancellation Policy: For details on our cancellation terms, please review our Cancellation Policy.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This symposium will offer the following credit types:

• AMA PRA Category 1 Credits™

• American Board of Internal Medicine's (ABIM) Maintenance of Certification

• American Board of Thoracic Surgery’s (ABTS) Maintenance of Certification

• ANCC Nursing Contact Hours (pending application approval)

We look forward to welcoming you to Memorial Sloan Kettering Cancer Center (MSK).

If you’ll be traveling to New York City from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, MSK has negotiated special rates and amenities at select hotels in Manhattan. Click here to view the list of select hotels and additional details on each.

For details on planning your visit to MSK, including travel and parking information, click here. Please note that parking validation is not available for attendees.

If you require any specific accommodations to attend this event in person, please contact [email protected] at least one week in advance.

MSK Symposium Directors 

Leontine J.R. van Elden, MD, PhD
Associate Attending, Pulmonary Service;
Assistant Professor of Clinical Medicine, Weill Cornell Medical College

Elizabeth Yogiaveetil, MD
Assistant Attending, Pulmonary Service;
Assistant Professor of Clinical Medicine, Weill Cornell Medical College

Christina M. Hess, AGACNP-BC
Nurse Practitioner, Pulmonary Service


MSK Symposium Planning Committee

Michelle Cavuoto, MA, RN, OCN®
Clinical Nurse IV

Mohit Chawla, MD, FCCP
Chief, Pulmonary Service

Catherine Oberg, MD
Assistant Attending, Pulmonary Service

Gopi I. Patel, MD
Assistant Attending, Pulmonary Service

A complete list of faculty and the full schedule brochure will be available soon.

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.